184 related articles for article (PubMed ID: 17994635)
21. Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia.
Kristensen K; Wide-Swensson D; Schmidt C; Blirup-Jensen S; Lindström V; Strevens H; Grubb A
Acta Obstet Gynecol Scand; 2007; 86(8):921-6. PubMed ID: 17653875
[TBL] [Abstract][Full Text] [Related]
22. Fetal-specific hypermethylated RASSF1A quantification in pregnancy.
Saraswathy S; Sahai K; Arora D; Krishnan M; Mendiratta SL; Biswas S; Abraham KM
J Matern Fetal Neonatal Med; 2017 Apr; 30(7):849-853. PubMed ID: 27165812
[TBL] [Abstract][Full Text] [Related]
23. Calreticulin in human pregnancy and pre-eclampsia.
Gu VY; Wong MH; Stevenson JL; Crawford KE; Brennecke SP; Gude NM
Mol Hum Reprod; 2008 May; 14(5):309-15. PubMed ID: 18417548
[TBL] [Abstract][Full Text] [Related]
24. Overproduction of the follistatin-related gene protein in the placenta and maternal serum of women with pre-eclampsia.
Pryor-Koishi K; Nishizawa H; Kato T; Kogo H; Murakami T; Tsuchida K; Kurahashi H; Udagawa Y
BJOG; 2007 Sep; 114(9):1128-37. PubMed ID: 17617189
[TBL] [Abstract][Full Text] [Related]
25. Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences--evaluation of diagnostic possibilities for predicting placental insufficiency.
Hromadnikova I; Zejskova L; Kotlabova K; Jancuskova T; Doucha J; Dlouha K; Krofta L; Jirasek JE; Vlk R
DNA Cell Biol; 2010 Jun; 29(6):295-301. PubMed ID: 20235876
[TBL] [Abstract][Full Text] [Related]
26. Serum markers of macrophage activation in pre-eclampsia: no predictive value of soluble CD163 and neopterin.
Kronborg CS; Knudsen UB; Moestrup SK; Allen J; Vittinghus E; Møller HJ
Acta Obstet Gynecol Scand; 2007; 86(9):1041-6. PubMed ID: 17712642
[TBL] [Abstract][Full Text] [Related]
27. [H19 expression in placenta with pre-eclampsia].
Zhao D; Li L; Yu LL; Lu LS; Han J; Chen XY; Zhou YG
Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):87-90. PubMed ID: 19570415
[TBL] [Abstract][Full Text] [Related]
28. Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia.
Crowley A; Martin C; Fitzpatrick P; Sheils O; O'Herlihy C; O'Leary JJ; Byrne BM
Prenat Diagn; 2007 Feb; 27(2):174-9. PubMed ID: 17191257
[TBL] [Abstract][Full Text] [Related]
29. Increased fetal RhD gene in the maternal circulation in early pregnancy is associated with an increased risk of pre-eclampsia.
Cotter AM; Martin CM; O'Leary JJ; Daly SF
BJOG; 2005 May; 112(5):584-7. PubMed ID: 15842281
[TBL] [Abstract][Full Text] [Related]
30. beta-globin DNA in maternal plasma as a molecular marker of pre-eclampsia.
Sekizawa A; Farina A; Koide K; Iwasaki M; Honma S; Ichizuka K; Saito H; Okai T
Prenat Diagn; 2004 Sep; 24(9):697-700. PubMed ID: 15386451
[TBL] [Abstract][Full Text] [Related]
31. Plasma adiponectin concentrations and placental adiponectin expression in pre-eclamptic women.
Ichida K; Moriyama T; Morita H; Kondo T; Yoshida S; Ohara N; Maruo T
Gynecol Endocrinol; 2007 Apr; 23(4):238-43. PubMed ID: 17505945
[TBL] [Abstract][Full Text] [Related]
32. Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction.
Rosta K; Molvarec A; Enzsöly A; Nagy B; Rónai Z; Fekete A; Sasvári-Székely M; Rigó J; Vér A
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):134-8. PubMed ID: 19108943
[TBL] [Abstract][Full Text] [Related]
33. Maternal urine for prenatal diagnosis--an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester.
Majer S; Bauer M; Magnet E; Strele A; Giegerl E; Eder M; Lang U; Pertl B
Prenat Diagn; 2007 Dec; 27(13):1219-23. PubMed ID: 17968856
[TBL] [Abstract][Full Text] [Related]
34. Decreased placental GCM1 (glial cells missing) gene expression in pre-eclampsia.
Chen CP; Chen CY; Yang YC; Su TH; Chen H
Placenta; 2004 May; 25(5):413-21. PubMed ID: 15081636
[TBL] [Abstract][Full Text] [Related]
35. Natriuretic peptide precursor B gene (TTTC)(n) microsatellite polymorphism in pre-eclampsia.
Szabó G; Molvarec A; Stenczer B; Rigó J; Nagy B
Clin Chim Acta; 2011 Jul; 412(15-16):1371-5. PubMed ID: 21514286
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients.
Nishizawa H; Pryor-Koishi K; Suzuki M; Kato T; Kogo H; Sekiya T; Kurahashi H; Udagawa Y
Mol Hum Reprod; 2008 Oct; 14(10):595-602. PubMed ID: 18805800
[TBL] [Abstract][Full Text] [Related]
37. Dynamic Changes of Fetal-Derived Hypermethylated RASSF1A and Septin 9 Sequences in Maternal Plasma.
Zhang L; Wang CM; Zhou WP; Chen QP; Zhou S; Lei W; Deng H; Zhang L; Liu GC
Reprod Sci; 2021 Apr; 28(4):1194-1199. PubMed ID: 33417202
[TBL] [Abstract][Full Text] [Related]
38. Cell-free fetal DNA in maternal circulation after chorionic villous sampling.
Di Tommaso M; Seravalli V; Salvianti F; Bussani C; Pasquini L; Cordisco A; Pinzani P
Prenat Diagn; 2013 Jul; 33(7):695-9. PubMed ID: 23658144
[TBL] [Abstract][Full Text] [Related]
39. Role of serum leptin level as a marker of severity of pre eclampsia.
Mumtaz F; Memon AR; Yousfani S; Tahir SM; Khushk I; Memon M; Memon A
J Ayub Med Coll Abbottabad; 2008; 20(1):13-5. PubMed ID: 19024177
[TBL] [Abstract][Full Text] [Related]
40. Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma.
Zhang M; Li T; Chen J; Li L; Zhou C; Wang Y; Liu W; Zhang Y
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):687. PubMed ID: 22038362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
